tiprankstipranks
AstraZeneca increases 2024 dividend by 7% to $3.10 per share
PremiumThe FlyAstraZeneca increases 2024 dividend by 7% to $3.10 per share
7d ago
Roche announces CE Mark for Ventana HER2 Rabbit Monoclonal Primary RxDx
PremiumThe Fly
Roche announces CE Mark for Ventana HER2 Rabbit Monoclonal Primary RxDx
8d ago
Nuvectis says NXP900 demonstrates robust activity in NSCLC
PremiumThe Fly
Nuvectis says NXP900 demonstrates robust activity in NSCLC
10d ago
AstraZeneca placed on ‘Positive Catalyst Watch’ at JPMorgan
PremiumThe FlyAstraZeneca placed on ‘Positive Catalyst Watch’ at JPMorgan
14d ago
AstraZeneca, Daiichi Sankyo datopotamab deruxtecan BLA accepted in the U.S.
PremiumThe Fly
AstraZeneca, Daiichi Sankyo datopotamab deruxtecan BLA accepted in the U.S.
16d ago
AstraZeneca announces FDA approval of Voydeya
PremiumThe Fly
AstraZeneca announces FDA approval of Voydeya
17d ago
AstraZeneca reports Ultomiris approved in U.S. for adults with NMOSD
PremiumThe FlyAstraZeneca reports Ultomiris approved in U.S. for adults with NMOSD
24d ago
AstraZeneca put volume heavy and directionally bearish
PremiumThe Fly
AstraZeneca put volume heavy and directionally bearish
28d ago
AstraZeneca reports follow up results from FLAURA2 Phase 3 trial
PremiumThe Fly
AstraZeneca reports follow up results from FLAURA2 Phase 3 trial
28d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100